Ventizz sells Gish Biomedical Inc. to Italian Sorin Group


June 11, 2010

Ventizz Capital Fund III L.P. has successfully sold its 100% interest in Gish Biomedical Inc., which produces medical products for heart surgery and cardiology, to the Italian Sorin Group. All of the parties have agreed not to disclose the purchase price.

Ventizz acquired Gish Biomedical, located in California (USA), in July 2007 in order to further drive the growth of MEDOS Medizintechnik AG, which was already majority-owned by Ventizz Fund III as part of its international expansion strategy. In future, MEDOS, which now operates in more than 60 countries, will increasingly focus on selling its newly developed generation of Deltastream blood pumps in Europe, and has sold Gish Biomedical Inc. for strategic reasons.

“The Sorin Group is an excellent fit as the new partner for Gish Biomedical,” commented Reinhard Löchner, member of the Managing Board and partner with Ventizz Capital Partners Advisory AG, which exclusively advises the Ventizz funds. “That makes us very confident that Sorin will successfully continue Gish Biomedical’s growth in future.”

Company profile

Ventizz Capital Partners was formed in 2000 and has offices in St. Gallen and Düsseldorf. Ventizz Capital Partners exclusively advises the Ventizz private equity funds that offer equity capital for the growth of high-tech companies in the German-speaking region. The four Partners of Ventizz advise together with a team of 15 professionals currently four funds with capital under management totaling EUR 675 million. Ventizz Capital Fund IV L.P. is the largest of the four funds set up to date. After six months of fund-raising, this fund was closed at the end of 2007 with a volume of EUR 450 million and is thus one of the largest private equity funds for venture capital and medium-sized tech buy outs in the German-speaking region.

To date, Ventizz funds have invested in 33 companies focusing on renewable energy, medical technology, information and communication technology and on other industries offering high value-add. In addition to a large number of trade sales, Ventizz has successfully taken three of its portfolio companies public (ersol, SAF, PV Crystalox Solar).




Press Contact Ventizz:

Sabine Menke

Phone:

+49. 211. 862 869. 36

Fax:

+49. 211. 862 869. 77

E-Mail:

s.menke@ventizz.com

Press Releases

Newsletter


     © Copyright 2005-2012 VENTIZZ Capital Partners